A Study of the Laparoscopically-placed Adjustable Gastric Band for the Management of Obesity in Adolescent Patients

Stopped early · Not applicable

Conditions studied: Obesity

In brief

This is a prospective, non-randomized, single center study of a laparoscopically placed, adjustable gastric band medical device for the treatment of adolescent obesity.

Key facts

Study ID

NCT01409928

Run by

University of Texas Southwestern Medical Center

People needed

16

Starts

2012-03-01

Expected to finish

2016-03-21

Last updated by the study team

2020-04-07

Who can join

Age: 14 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI >= 35 kg/m2 and at least one serious comorbidity (type 2 diabetes mellitus, moderate or severe obstructive sleep apnea, pseudotumor cerebri, and severe steatohepatitis)
• BMI => 40 kg/m2 and a serious comorbidity (as listed above or at least one other comorbidity (mild obstructive sleep apnea, hypertension, insulin resistance, glucose intolerance, dyslipidemia, impaired quality of life or activities of daily living)
• Must live in Dallas/Fort Worth area so that necessary follow-up can be ensured.

You may not qualify if…

• Intention to have another surgical procedure for weight reduction within 12 months of LAP-BAND® placement
• History of pregnancy, or the intention to become pregnant within the next 12 months
• History of substance abuse within one year prior to surgery
• Obesity caused by medically correctable condition
• History of gastric or esophageal surgery, or the presence of an esophageal dysmotility disorder
• Eating disorder that is untreated
• Chronic use of aspirin and/or nonsteroidal anti-inflammatory medications and unwillingness to discontinue the use of these medications
• History of previous bariatric surgery, intestinal obstruction, or peritonitis
• Presence of localized or systemic infection at the time of surgery
• History of congenital or acquired anomalies of the gastrointestinal tract
• History of immunocompromise, or auto-immune, hematologic or dermatologic condition that increases risk of bleeding, breakdown of skin integrity (due to port), or infection.
• Planning to or having high likelihood of moving out of region within 2 years
• Portal Hypertension or Cirrhosis
• Uncorrectable coagulopathy or severe bleeding disorder
• Use of weight loss medications within 6 weeks of procedure

Where it is running

• Children's Medical Center Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.